Amedisys Inc (AMED)

Debt-to-equity ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 1,134,540 1,147,760 1,125,200 1,088,180 1,066,510 1,039,910 1,006,780 1,079,120 1,051,570 1,015,740 985,646 966,758 931,351 905,264 874,272 788,153 809,224 756,205 720,851 679,197
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,134,540K
= 0.00

Amedisys Inc has consistently maintained a debt-to-equity ratio of 0.00 for the past several periods, from March 31, 2020, to December 31, 2024. This indicates that the company has no debt in relation to its equity during these periods. A debt-to-equity ratio of zero signifies that the company is not relying on debt to finance its operations or growth, and it has a strong financial position in terms of capital structure. A low or zero debt-to-equity ratio is generally seen as positive, as it suggests lower financial risk and greater financial stability for the company.

Amedisys Inc's consistent zero debt-to-equity ratio reflects a prudent financial management strategy focused on maintaining a healthy balance between debt and equity. This stability in the company's capital structure suggests that it may be funding its operations and investments primarily through equity or retained earnings, rather than taking on debt. Investors and creditors often view a low debt-to-equity ratio favorably as it indicates a lower risk profile for the company and a stronger financial foundation.


Peer comparison

Dec 31, 2024